Findings of stroke-induced neurogenesis in the adult brain have raised hopes that amplification of endogenous neurogenesis contributes to improvement of neurological outcomes. This article briefly reviews stroke-induced neurogenesis and emerging potential therapies aimed at amplification of endogenous neurogenesis during stroke recovery.
In the adult rodent brain, neurogenesis occurs primarily in the subventricular zone (SVZ) of the lateral ventricle and in the subgranular zone (SGZ) of the dentate gyrus, and neurogenesis persists for the lifetime of the animal. [1] [2] [3] [4] [5] [6] [7] [8] [9] In the adult human brain, neurogenesis occurs in the hippocampus and SVZ. 10 Studies in experimental stroke demonstrate that focal cerebral ischaemia increases neurogenesis in the SVZ and induces SVZ neuroblast migration towards the ischaemic boundary. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Stroke-induced neurogenesis is present in the adult human brain, even in advanced-age patients. 26, 27 Findings of endogenous neural progenitor cell reservoirs in response to brain injury in the adult brain have raised hopes that amplification of endogenous neurogenesis may replace damaged neurons and stimulate restorative processes in the brain microenvironment, which may subsequently improve neurological outcomes. This article briefly reviews stroke-induced neurogenesis and emerging potential therapies aimed at amplification of endogenous neurogenesis during stroke recovery.
Stroke Induces Neurogenesis
In the rodent, neural stem cells in the adult SVZ generate neuroblasts that travel the rostral migratory stream to the olfactory bulb, where they differentiate into granule and periglomerular neurons. [28] [29] [30] Neuroblasts generated in the SGZ differentiate into dentate granule cells and integrate into pre-existing neuronal networks. More than 30,000 neuroblasts are generated daily in the rodent SVZ. 31,32 Neural stem cells are present in the SVZ of the adult human brain.
33,34
Although the cellular composition and cytoarchitecture of the adult human SVZ differ from those of the adult rodent SVZ, the presence of a human rostral migratory stream organised around a lateral ventricular extension to the olfactory bulb has been demonstrated. 35 Stroke induces neurogenesis that involves proliferation, differentiation and migration of neural progenitor cells. 
Therapies Enhance Endogenous Neurogenesis
Endogenous neurogenesis in response to stroke is limited and only a small population of newly generated neurons survives, while the vast majority of neuroblasts die in the ischaemic boundary regions. 16, 18, 42 There are emerging therapies in experimental stroke which aim to amplify endogenous neurogenesis and to improve the ischaemic microenvironment to be receptive to integration of newly arriving cells within the tissue. These therapies are usually initiated days after stroke, which differ from neuroprotective therapies that start within hours after stroke onset.
Infusion of a variety of neurotrophic and growth factors, including basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) and brain-derived neurotrophic factor (BDNF), into the lateral ventricle of the rodent with stroke further increases neurogenesis. 63 Administration of cerebrolysin to the rat 24-48 hours after stroke significantly increases neurogenesis and improves neurological outcome 28 days after stroke. 64 Cerebrolysin enhances proliferation and differentiation of SVZ neural progenitor cells and increases numbers of neuroblasts migrating to ischaemic boundary regions. 64 Vascular endothelial growth factor (VEGF) is an angiogenic growth factor. 65 Intraventricular infusion of VEGF increases neurogenesis in the SVZ and dentate gyrus of adult mice. 66 Treatment with VEGF 24 hours after stroke enhances angiogenesis and neurogenesis. 66, 67 In addition to its role in erythroid progenitors, endogenous erythropoietin (EPO), through its receptor, EPOR, regulates neurogenesis in the adult rodent brain. 68, 69 
